All In Biotech

Drug Trial Radar · NCT06610773

HUC-MSC for Treatment of High-risk HPV Infection

Effectiveness and Safety of Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of HPV High-risk Infection

Last checked: Nov 19, 2026Latest source record: Sep 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Mar 1, 2024

Primary completion

Sep 10, 2025

Study completion Sep 10, 2026

Sponsor

Lead sponsor
Shanghai East HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 25 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and initial effectiveness of human umbilical cord mesenchymal stem cells in HPV clearance.

Conditions

  • Human Papillomavirus Viruses
  • Mesenchymal Stem Cells

Interventions

  • hUC-MSCsBiological

    1×10\^6/Kg hUC-MSCs (suspended in 100 mL normal saline containing 5% albumin) are infused intravenously to patients at a controlled rate of 60-80 drops/min.

  • Saline+albuminBiological

    Normal saline containing 5% albumin had a similar suspension and appearance package to hUC-MSCs, but no MSCs

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse events-The incidence rate of allergic reactionTime frame: 1day,1st,4th,12th,and 36th week
  2. The 24 type HPV viral loadTime frame: -28th~0day,4th,12th,and 36th week

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Shanghai East Hospital, Tongji University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.